SPOTLIGHT -
Sephin1 Therapy Could Be Effective Therapy for Multiple Sclerosis
Sephin1 found to protect oligodendrocytes, axons, and myelin, as well as reduce central nervous system inflammation in multiple sclerosis.
Read More
Phase 3 Trial for Oral Multiple Sclerosis Combo Nears Finish Line
Trial comparing oral ponesimod versus teriflunomide (Aubagio) in relapsing multiple sclerosis will evaluate annualized relapse rate as well as other disease activity measures.
